Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Executive Summary
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.